Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access February 4, 2014

Usefulness of Reynolds Risk Score in men with stable angina

  • Inga Pietka EMAIL logo , Agata Sakowicz , Tadeusz Pietrucha , Anna Cichocka-Radwan and Malgorzata Lelonek
From the journal Open Medicine


[1] Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL, Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation, 2004, 109(1): IV6–19 10.1161/01.CIR.0000133444.17867.56Search in Google Scholar PubMed

[2] Hansson GK, Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med, 2005, 352,1685–1695 in Google Scholar PubMed

[3] Libby P, Theroux P, Pathophysiology of coronary artery disease. Circulation, 2005, 111,3481–3488 in Google Scholar PubMed

[4] Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al., Centers for Disease Control and Prevention; American Heart Association, Markers of Inflammation and Cardiovascular Disease Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 2003, 107,499–511 in Google Scholar PubMed

[5] Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, et al., C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet, 2010, 375,132–140 in Google Scholar PubMed PubMed Central

[6] Ridker PM, Buring JE, Rifai N, Cook NR, Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA, 2007, 297,611–619 in Google Scholar PubMed

[7] Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR, C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation, 2008, 118,2243–2245 in Google Scholar PubMed PubMed Central

[8] Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA, 2001, 285,2486–2497 10.1001/jama.285.19.2486Search in Google Scholar PubMed

[9] Gohlke H, Winter M, Karoff M, Held K, CARRISMA: a new tool to improve risk stratification and guidance of patients in cardiovascular risk management in primary prevention. Eur J Cardiovasc Prev Rehabil, 2007, 14,141–148 in Google Scholar PubMed

[10] Collins GS, Altman DG, An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. Br Med J, 2009, 339,b2584–b2593 in Google Scholar PubMed PubMed Central

[11] Collins GS, Altman DG, An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. Br Med J, 2010, 340,c2442–c2450 in Google Scholar PubMed PubMed Central

[12] Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM, Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet, 2008, 371,923–931 in Google Scholar PubMed PubMed Central

[13] O’Donnell CJ, Elosua R, Cardiovascular risk factors. Insights from Framingham Heart Study. Rev Esp Cardiol, 2008, 61,299–310 10.1016/S1885-5857(08)60118-8Search in Google Scholar

[14] Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, et al., Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol, 2002, 156, 871–881 in Google Scholar PubMed

[15] Okwuosa TM, Greenland P, Ning H, Liu K, Bild DE, Burke GL, Eng J, et al., Distribution of coronary artery calcium scores by Framingham 10-Year risk strata in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol, 2011, 57,1838–1845 in Google Scholar PubMed PubMed Central

[16] DeFilippis AP, Blaha MJ, Ndumele CE, Budoff MJ, Lloyd-Jones DM, McClelland RL, et al., The association of Framingham and Reynolds Risk Scores with incidence and progression of coronary artery calcification in MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol, 2011,58,2076–2083 in Google Scholar PubMed PubMed Central

[17] Heeschen C, Dimmeler S, Fichtlscherer S, Hamm CW, Berger J, Simoons ML, et al., CAPTURE Investigators, Prognostic value of placental growth factor in patients with acute chest pain. JAMA, 2004,291, 435–441 in Google Scholar PubMed

[18] Lenderink T, Heeschen C, Fichtlscherer S, Dimmeler S, Hamm CW, Zeiher AM, et al., CAPTURE Investigators: Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes. J Am Coll Cardiol, 2006, 47,307–311 in Google Scholar PubMed

[19] Silaghi AC, Pais R, Valea A, Mironiuc AI, Silaghi H, Epicardial adipose tissue and relationship with coronary artery disease. Centr Eur J Med, 2011, 6,251–262 in Google Scholar

Published Online: 2014-2-4
Published in Print: 2014-2-1

© 2013 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 2.3.2024 from
Scroll to top button